Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 29, 2026
Reporting Period: Quarter ended March 31, 2026
This filing serves as a notification that Humana Inc. has issued a press release and detailed earnings release regarding its financial results for the first quarter of fiscal year 2026. The filing incorporates by reference the press release, earnings release, and management's prepared remarks.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data. The filing states that detailed financial metrics, including revenue, profit, cash flow, margins, debt, and liquidity, are contained in the attached exhibits (Exhibit 99.1, 99.2, and 99.3) and on the company's Investor Relations website. No specific values are present in this document.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms that results for the quarter ended March 31, 2026, have been reported. Investors must refer to the incorporated exhibits for comparative analysis.
Guidance, Outlook, and Risks
Outlook and Guidance: The filing indicates that management's prepared remarks include expectations for future earnings. These remarks are attached as Exhibit 99.3 but are not summarized in the text of this Form 8-K.
Risks and Contingencies: No specific risks, contingencies, or unusual items are detailed in this cover document. Such disclosures, if any, would be located within the attached earnings release or management remarks.
Investor Verification Checklist
- Verify the specific revenue and net income figures for the quarter ended March 31, 2026, in Exhibit 99.2 (Earnings Release).
- Review management's prepared remarks (Exhibit 99.3) for updated full-year 2026 guidance and expectations.
- Confirm any changes in medical cost trends or regulatory impacts discussed in the detailed earnings release.
- Check the company's Investor Relations website at www.humana.com for the full statistical pages referenced in the filing.